1975
DOI: 10.1016/0005-2736(75)90028-0
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of glucose transport into brain by phlorizin, phloretin and glucose analogues

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
13
0

Year Published

1980
1980
2016
2016

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 68 publications
(14 citation statements)
references
References 23 publications
1
13
0
Order By: Relevance
“…Phloretin was subsequently found to block sugar uptake in intestinal tissue [51], drawing significant interest to its application in the treatment of diabetes. Phloretin was shown to specifically inhibit GLUT2 and to a lesser extent SGLT1 [22,52]. Here, we show that phloretin inhibits the transport of GLUT2 between the apical and basal membranes in both directions.…”
Section: Discussionsupporting
confidence: 54%
See 1 more Smart Citation
“…Phloretin was subsequently found to block sugar uptake in intestinal tissue [51], drawing significant interest to its application in the treatment of diabetes. Phloretin was shown to specifically inhibit GLUT2 and to a lesser extent SGLT1 [22,52]. Here, we show that phloretin inhibits the transport of GLUT2 between the apical and basal membranes in both directions.…”
Section: Discussionsupporting
confidence: 54%
“…It is thought that phloretin exerts its effect by binding to GLUT2 and SGLT1 rsob.royalsocietypublishing.org Open Biol. 4: 140091 [22,23]. However, other work showed phloretin inhibits PKC [24], suggesting it might directly affect GLUT2 translocation.…”
Section: Phloretin Blocks Both Basal and Apical Glut2 Translocationmentioning
confidence: 99%
“…3 , n =6), supporting the conclusion that enhanced PMO uptake was mediated by saturable active transport of GF rather than by osmotic effects. Finally, intramuscular co-administration of PMO-GF with phloretin, an inhibitor of glucose and fructose transporters 20 , abolished the potentiating effect of GF on PMO activity ( Fig. 3h,i ).…”
Section: Resultsmentioning
confidence: 88%
“…Cy5-labelled 2′OMe and siRNA were purchased from TriLink BioTechnologies (San Diego, CA, USA) and Eurogentec (LIEGE Science Park, Belgium), respectively. Both PMO (5′- ggccaaacctcggcttacctgaaat -3′) and 2′OMe AO (5′- ggccaaacctcggcttacct -3′) sequences were targeted to the murine dystrophin exon23/intron23 boundary site as reported 7 20 . Glyceraldehyde 3-phosphate dehydrogenase siRNAs used were sense 5′- CAGAAGACUGU GGAUGGCC -3′ (DTDT) and antisense 5′- GGCCAUCCACAGUCUUCUG -3′ (DGDG) 11 .…”
Section: Methodsmentioning
confidence: 99%
“…3 ) is in line with reports for other reactive carbonyl species. In terms of pharmacological applicability it should be noted that phloretin inhibits glucose uptake into brain and brain endothelial cells in vitro [49] and in vivo [50,51] .…”
Section: Discussionmentioning
confidence: 99%